A comparison of polychemotherapy and melphalan/prednisone for primary remission induction, and interferon-alpha for maintenance treatment, in multiple myeloma. A prospective trial of the German Myeloma Treatment Group.

Peest, D; Deicher, H; Coldewey, R; Leo, R; Bartl, R; Bartels, H; Braun, H J; Fett, W; Fischer, J T; Göbel, B

Peest, D; Deicher, H; Coldewey, R; Leo, R; Bartl, R; Bartels, H; Braun, H J; Fett, W; Fischer, J T; Göbel, B.

Affiliation

Peest D; Abt. Immunologie und Transfusionsmedizin, Zentrum Innere Medizin und Dermatologie, Medizinische Hochschule Hannover, Germany.

Eur J Cancer ; 31A(2): 146-51, 1995.

Article in En | MEDLINE | ID: mdl-7718318

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Multiple Myeloma/therapy; Aged; Carmustine/administration & dosage; Dexamethasone/administration & dosage; Doxorubicin/administration & dosage; Female; Humans; Interferon-alpha/therapeutic use; Male; Melphalan/administration & dosage; Middle Aged; Multiple Myeloma/mortality; Prednisone/administration & dosage; Prospective Studies; Remission Induction; Survival Rate; Vincristine/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Multiple Myeloma Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 1995 Document type: Article Affiliation country: Germany Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links